Shoulder Innovations Inc（SI）資訊與事件SIShoulder Innovations Inc

Shoulder Innovations Appoints Jon Osborne as Chief Commercial Officer

Shoulder Innovations announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6. Osborne, who most recently served as VP of Commercial Development, will now have responsibility for all elements of Shoulder Innovations' commercial organization. Prior to joining Shoulder Innovations as VP of Commercial Development in September 2023, Osborne held several positions of increasing responsibility from 2014 to 2023 at Smith & Nephew, most recently as VP of Commercial Marketing for the Sports Medicine business in the Americas. Earlier in his career at Smith & Nephew, he also served as an Area Vice President of Sales and as Director of Global Marketing, where he launched products and built distribution across six continents. Prior to Smith & Nephew, Osborne worked in sales management, global marketing, and general management from 1998 to 2014 in both domestic and international markets at ArthroCare Corporation, Tornier USA, and Team Surgical.

Shoulder Innovations Files $300M Mixed Securities Shelf

Shoulder Innovations files $300M mixed securities shelf

Shoulder Innovations Q2 Revenue $17.2M Beats Expectations

Reports Q2 revenue $17.2M, consensus $16.57M. "Our Q2 results build on a strong start to the year and reflect remarkable momentum across every dimension of our business," said Rob Ball, CEO. "We continued to rapidly onboard new surgeons against a large, underpenetrated market opportunity, deepened utilization within our existing surgeon base, and advanced a broad and increasingly differentiated product pipeline. This performance resulted in net revenue growth of 56% and implant volume growth of approximately 50%, enabling us to increase our outlook for the full year. Our confidence in what lies ahead has never been stronger. The commercial organization we've built continues to perform, our innovation pipeline is growing, and our conviction in the team's ability to execute is high. With a strengthened financial foundation following our recent debt refinancing, we believe Shoulder Innovations remains in the early stages of what we can accomplish in transforming shoulder surgical care, and we look forward to demonstrating that in the back half of 2026 and beyond."